Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxicity testing: creating a revolution based on new technologies.

Nirmala Bhogal1, Christina Grindon, Robert Combes

  • 1FRAME (Fund for the Replacement of Animals in Medical Experiments), Russell and Burch House, 96-98 North Sherwood Street, Nottingham NG1 4EE, UK.

Trends in Biotechnology
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethics and Controversies in Animal Subjects Research and Impact on Clinical Decision-Making.

Anesthesiology clinics·2024
Same author

60 Years of the 3Rs symposium: Lessons learned and the road ahead.

ALTEX·2024
Same author

<i>Alternatives to Laboratory Animals</i>: Trends in <i>Replacement</i> and the Three Rs.

Alternatives to laboratory animals : ATLA·2022
Same author

Clinical impact of high-profile animal-based research reported in the UK national press.

BMJ open science·2022
Same author

It's Time to Include Harm to Humans in Harm-Benefit Analysis - But How to Do It, That is the Question.

Alternatives to laboratory animals : ATLA·2021
Same author

It's Time to Reconsider <i>The Principles of Humane Experimental Technique</i>.

Alternatives to laboratory animals : ATLA·2020
Same journal

Periphytic biofilms entrap CO<sub>2</sub> from industrial gas mixtures.

Trends in biotechnology·2026
Same journal

CRISPR/Cas14a-based logic system for intelligent microplastic monitoring based on multiple DNA walking mechanisms.

Trends in biotechnology·2026
Same journal

Smart biomaterials: From responsiveness to closed-loop sensing and feedback.

Trends in biotechnology·2026
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
See all related articles

Novel biotechnology advances are slow to impact chemical safety testing. This review explores new methods for toxicological evaluation to meet regulatory demands and protect human health.

Area of Science:

  • Biotechnology
  • Toxicology
  • Risk Assessment

Background:

  • Biotechnology is rapidly advancing, particularly in drug discovery through high-throughput screening.
  • The integration of these biotechnological advances into chemical toxicological assessment has lagged.
  • Increasing regulatory demands for chemical toxicity testing necessitate new methodologies.

Purpose of the Study:

  • To review the current and future value of novel biotechnologies in toxicological evaluation.
  • To assess the application of new methods for hazard identification and risk assessment.
  • To explore how these technologies can enhance the protection of human health.

Main Methods:

  • Review of current literature on biotechnological applications in toxicology.

Related Experiment Videos

  • Analysis of emerging technologies for hazard identification.
  • Evaluation of novel methodologies for risk assessment.

    • Main Results:

    • The application of high-throughput and miniaturized screening in toxicology is currently limited but growing.
    • New technologies offer significant potential for more efficient and accurate toxicological evaluation.
    • Regulatory drivers are pushing for the adoption of these innovative approaches.

    Conclusions:

    • Novel biotechnologies are crucial for meeting future regulatory toxicity testing demands.
    • These advancements are essential for improving hazard identification and risk assessment processes.
    • The integration of new methodologies will significantly contribute to safeguarding human health.